{
  "pmid": "36107212",
  "uid": "36107212",
  "title": "Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.",
  "abstract": "PURPOSE: To develop a risk score based on a prognostic model and a nomogram integrating baseline clinicopathological variables to predict bladder cancer-specific survival (BCSS) to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC) patients. METHODS: We retrospectively identified a consecutive sample of 247 MIBC patients treated with cisplatin-based NAC-plus-cystectomy in two Spanish hospitals between 2000 and 2019. Age at MIBC diagnosis, sex, histology, lymphovascular invasion, previous non-MIBC, hydronephrosis, and clinical TNM were included in the initial Cox regression model. A risk score was computed based on the final prognostic model and a nomogram was used to estimate BCSS at 2 and 5 years. RESULTS: Median age was 66 years; 89% were males; 83% had pure urothelial carcinoma; 16.2% had previous non-MIBC. Clinical stage was T2N0, T3-4aN0, and Tx-4N + in 24%, 57%, and 19% of patients, respectively. Complete pathological response was seen in 29.4% and downstaging to non-MIBC (ypT1, ypTa, ypTis) in 12.5% of patients. Overall 5-year BCSS was 59%. Four prognostic factors were identified: variant histology, previous non-MIBC, female sex and hydronephrosis. By adding the points attributed to each of these factors, we categorized patients in three groups: low-risk (0 points); intermediate-risk (1-9 points); high-risk (≥ 10 points). Five-year BCSS was 72%, 53%, and 15%, respectively (p < 0.0001). CONCLUSION: We developed a nomogram and risk score based on four baseline clinicopathological characteristics to predict BCSS to NAC-plus-cystectomy in MIBC patients. If validated in prospective studies, this nomogram can be useful for selecting patients likely to benefit from NAC.",
  "authors": [
    {
      "last_name": "Font",
      "fore_name": "Albert",
      "initials": "A",
      "name": "Albert Font",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain. afont@iconcologia.net.",
        "Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain. afont@iconcologia.net."
      ]
    },
    {
      "last_name": "Domenech",
      "fore_name": "Montserrat",
      "initials": "M",
      "name": "Montserrat Domenech",
      "affiliations": [
        "Medical Oncology Department, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Buisan",
      "fore_name": "Oscar",
      "initials": "O",
      "name": "Oscar Buisan",
      "affiliations": [
        "Urology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Lopez",
      "fore_name": "Hector",
      "initials": "H",
      "name": "Hector Lopez",
      "affiliations": [
        "Urology Department, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain."
      ]
    },
    {
      "last_name": "González",
      "fore_name": "Andrea",
      "initials": "A",
      "name": "Andrea González",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Etxaniz",
      "fore_name": "Olatz",
      "initials": "O",
      "name": "Olatz Etxaniz",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain.",
        "Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Matas",
      "fore_name": "Marta",
      "initials": "M",
      "name": "Marta Matas",
      "affiliations": [
        "Medical Oncology Department, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Elias",
      "fore_name": "Xavier",
      "initials": "X",
      "name": "Xavier Elias",
      "affiliations": [
        "Urology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Gomez",
      "fore_name": "Maica",
      "initials": "M",
      "name": "Maica Gomez",
      "affiliations": [
        "Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Figols",
      "fore_name": "Mariona",
      "initials": "M",
      "name": "Mariona Figols",
      "affiliations": [
        "Medical Oncology Department, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Horneros",
      "fore_name": "Judith",
      "initials": "J",
      "name": "Judith Horneros",
      "affiliations": [
        "Radiology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Pardo",
      "fore_name": "Juan Carlos",
      "initials": "JC",
      "name": "Juan Carlos Pardo",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain.",
        "Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Notario",
      "fore_name": "Lucia",
      "initials": "L",
      "name": "Lucia Notario",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain.",
        "Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Ruiz de Porras",
      "fore_name": "Vicenç",
      "initials": "V",
      "name": "Vicenç Ruiz de Porras",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain.",
        "Badalona Applied Research Group in Oncology (B-ARGO), Institut Català d'Oncologia - Germans Trias i Pujol Research Institute, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Perez",
      "fore_name": "Ignacio",
      "initials": "I",
      "name": "Ignacio Perez",
      "affiliations": [
        "Medical Oncology Department, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Areal",
      "fore_name": "Joan",
      "initials": "J",
      "name": "Joan Areal",
      "affiliations": [
        "Urology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain."
      ]
    },
    {
      "last_name": "Esteve",
      "fore_name": "Anna",
      "initials": "A",
      "name": "Anna Esteve",
      "affiliations": [
        "Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, 08972, Barcelona, Spain."
      ]
    }
  ],
  "journal": {
    "title": "World journal of urology",
    "iso_abbreviation": "World J Urol",
    "issn": "1433-8726",
    "issn_type": "Electronic",
    "volume": "40",
    "issue": "11",
    "pub_year": "2022",
    "pub_month": "Nov"
  },
  "start_page": "2627",
  "end_page": "2634",
  "pages": "2627-2634",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Male",
    "Humans",
    "Female",
    "Aged",
    "Urinary Bladder Neoplasms",
    "Neoadjuvant Therapy",
    "Carcinoma, Transitional Cell",
    "Nomograms",
    "Prospective Studies",
    "Retrospective Studies",
    "Neoplasm Invasiveness",
    "Cystectomy",
    "Muscles",
    "Hydronephrosis"
  ],
  "article_ids": {
    "pubmed": "36107212",
    "doi": "10.1007/s00345-022-04147-4",
    "pii": "10.1007/s00345-022-04147-4"
  },
  "doi": "10.1007/s00345-022-04147-4",
  "dates": {
    "completed": "2022-11-01",
    "revised": "2022-11-01"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:23:40.176930",
    "pmid": "36107212"
  }
}